mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.08 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.08 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.08 |